Получение флюмазенила, меченного фтором-18, нового радиолиганда для позитронной эмиссионной томографии

Список литературы

1. Phelps М. Е, Maziotta J.C., and Schelberg H.R. Positron Emission Tomography. Principles and application for the brain and heart// 2002 Raven Press, New York, USA.
2. Dobrucki L.W., Sinusas A.J., Cardiovascular Molecular. Imaging Seminar in nuclear medicine// 2005. Elsevier.
3. Красикова P.H. Роботизированный синтез радиофармпрепаратов для позитронной эмиссионной томографии// Радиохимия, 1998, V.40,1.4, р. 352−360
4. Nutt R. The History of Positron Emission Tomography// 2002, V. 4, I. 1, p. 1126.
5. Humm J. L., Rosenfeld A., Alberto D. G. From PET detectors to PET scanners// European Journal of Nuclear Medicine and Molecular Imaging, 2003, V. 30, N. 11, p. 1575 -1597
6. Jerusalem G., Hustinx R., Beguin Y. and Fillet G. PET scan imaging in
7. Л oncology// European Journal of Cancer, 2003 V.39, L 11, p. 1525−1534 w
8. Talbot J. N., Petegnief Y., Kerrou K., Montravers F., Grahek D. and Younsi N.1 R
9. Positron emission tomography with F.-FDG in oncology. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment// 2003, V. 504,1. 1−3, p. 129−138
10. Gupta N., Price P. M. and Aboagye E. O. PET for in vivo pharmacokinetic and pharmacodynamic measurements. European Journal of Cancer// 2002, V. 38,1. 16, p. 2094−2107
11. Hiroshi F. and Kazuo K. Recent developments and future aspects of nuclear medicine in oncology// International Congress Series. 2002, V. 1228, p. 107−116
12. Bomanji J. В., Costa D. C. and Ell P. J. Clinical role of positron emission tomography in oncology//The Lancet Oncology, 2001, V. 2,1. 3, p. 157−164
13. Knuuti J. Clinical cardiac PET in the future// European Journal of Nuclear Medicine and Molecular Imaging, 2004, V. 31(4), p. 467−468.10
14. Bengel F.M. and Schwaiger M. Assessment of cardiac sympathetic neuronal function using PET imaging// Journal of Nuclear Cardiology, 2004, V. 11, I. 5, p. 603−61 611
15. Hesse S., Barthel H., Schwarz J., Sabri O. and Miiller U. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders// Neuroscience & Biobehavioral Reviews, 2004, V. 28,1. 6, p. 547−563
16. Piccini P. and Whone A. Functional brain imaging in the differential diagnosis of Parkinson’s disease//The Lancet Neurology, 2004, V. 3,1. 5, p. 284−290
17. Demetriades A.K. Functional neuroimaging in Alzheimer’s type dementia// Journal of the Neurological Sciences, 2002, V. 203−204, p. 247−251
18. Talbot P. S. and Laruelle M. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.//
19. European Neuropsychopharmacology, 2002, V. 12,1. 6, p. 503−511
20. Humm J. L., Rosenfeld A., Guerra A. D: From PET detectors to PET scanners// European Journal of Nuclear Medicine and Molecular Imaging, 2003, V. 30, I. 11, p.1575−1597
21. Vaalburg W., Kamphuis J.A., Beerling-van der Molen H.D. An improved method for the cyclotron production of I3N-labeled ammonia// Journal Applied Radiation and Isotopes, 1975, V. 26, p. 316−318.
22. Welch M.J., Straatmann M.G. The reaction of recoil N atoms with some organic compounds in the sold and liquid phases// Radiochimica Acta, 1973, V. 20, p. 124−129.
23. Wieland В., Bida G., Padgett H. In-target production of N. ammonia via proton irradiation of dilute aqueous ethanol and acetic acid mixtures// Journal Applied Radiation and Isotopes, 1991, V. 42, I. I 1, p. 1095−1098.
24. Berridge M.S. and’Landmeier B.J. In-target production of 13N. ammonia: Target design, products, and operating parameters// Applied Radiation and Isotopes, 1993, V. 44,1. 12, p. 1433−14 411. J ^
25. Krasikova R.N., Fedorova O.S., Korsakov M.V., Landmeier B.B., Berridge M.S. Improved 13N. ammonia yield from water targets using methane gas// Journal Applied Radiation and Isotopes 1999, V. 51,1. 4, p. 395−401.
26. Brinkman G. A. In-beam production of labeled compounds//The International Journal of Applied Radiation and Isotopes. 1982, V. 33,1. 7, p. 525−532
27. Comar D, Cartron J, Maziere M, Marazano C. Labelling and metabolism of methionine-methyl-nC// European Journal of Nuclear Medicine and Molecular Imaging, 1976, V. 1,1.1, p. 11−4.28
28. Корсаков M.B., Красикова P.H., Соловьев Д. В. Роботизированный синтез L-пС-метил.метионина// Радиохимия, 1994, V. 36,1. 3, р. 272−274.
29. Larsen P., Ulin, J, Dahlstrom K., Jensen M. Synthesis of nC. iodomethane by iodination of [nC]methane// Journal Applied Radiation and Isotopes, 1997, V. 48, p. 153−157.
30. Noguchi J., Suzuki K. Automated synthesis of the ultra high specific activity of llC. Ro 15−4513 and its application in an extremely low concentration region to an ARG study// Nuclear Medicine and Biology, 2003, V. 30, p. 335−343.
31. Suzuki K., Yamazaki Т., Sasaki M., Kubodera A. Specific activity of llC. C02 in a N2 gas target: effect of irradiation dose, irradiation history, oxygen content and beam energy// Radiochim Acta 2000, V. 88, p. 211−215.
32. Jewett DM. A simple synthesis of nC. methyl triflate// Int J Rad Appl Instram [А]. 1992, V. 43,1. 11, p. 1383−5.-j о
33. Wilson AA, Garcia A, Jin L, Houle S. Radiotracer synthesis from nC. iodomethane: a remarkably simple captive solvent method// Nuclear Medicine and Biology, 2000, V. 27,1. 6, p. 529−532.
34. Bolton R. Isotopic methylations// J Label Compds Radiopharm. 2001, V. 44, p. 701−736.
35. Varagnolo L., Stokkel M. P., Mazzi U. and Pauwels E. K. J.18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG// Nuclear Medicine and Biology, 2000, V. 27,1. 2, p. 103−112
36. Smart В. E.- Fluorine substituent effects (on bioactivity)// Journal of Fluorine Chemistry. 2001, V. 109,1. 1, p. 3−11
37. Ismail F. M. D.- Important fluorinated drugs in experimental and clinical use// Journal of Fluorine Chemistry, 2002, V. 118,1. 1−2, p. 27−33
38. Dolbier W R. Fluorine chemistry at the millennium// Journal of Fluorine Chemistry, 2005, V. 26,1. 2, p. 157−163
39. Nickles R. J. The production of a broader palette of PET Tracers. J Label Compd Radiopharm. 2003, V. 46, p. 1−27.
40. Knapp F.F. Jr, Mirzadeh S. The continuing important role of radionuclide generator systems for nuclear medicine// European Journal of Nuclear Medicine and Molecular Imaging, 1994, V. 21,1.10, p. 1151−65.
41. Welch MJ, McCarthy TJ. The potential role of generator-produced radiopharmaceuticals in clinical PET// European Journal of Nuclear Medicine and Molecular Imaging, 2000, V. 41,1. 2, p. 315−7.
42. Maecke H.R., Hofmann M., Haberkorn U. (68)Ga-labeled peptides in tumor imaging// Nuclear Medicine, 2005, V. 46 (Suppl 1), p. 172−8.
43. Kilborn M.R. Fluorine-18 labeling of radiopharmaceuticals// Nuclear Science Series, NAS-NS-3203 National Academy Press, Washington DS, 1990.
44. Stocklin G., Pike V.W. Radiopharmaceuticals for Positron Emission Tomography: Methodological Aspects (Developments in Nuclear Medicine)// Klunder Academic Publisher, 1993.
45. Zeisler S. K., Becker D. W., Pavan R. A., Moschel R. and Ruhle H. A water-cooled spherical niobium target for the production of 1SF. fluoride// Applied Radiation and Isotopes, 2000, V. 53,1. 3, p. 449−453
46. Hess E., Blessing G., Goenen H.H., Qaim S.M. Improved target system for production of high purity// Applied Radiation and Isotopes, 2000, V. 52,1. 6, p. 143 140.
47. Carlos E. Lepera G. and Dembowski B. Production of 18 °F.fluoride with a high-pressure disposable [180]water target//. Applied Radiation and Isotopes, 1997, V. 48,1. 5, p. 613−6171 1Я
48. Alexoff D., Schlyer D.J. and Wolf А.Р. Recovery of 18 °F.fluoride from [180]water in an electrochemical cell. International Journal of Radiation Applications and Instrumentation. Part A// Applied Radiation and Isotopes. 1989, V. 40, L 1, p. 1−6
49. Hamacher K., Hirschfelder Т., Coenen HH. Electrochemical cell for separation of 18 °F.fluoride from irradiated 180-water and subsequent no carrier added nucleophilic fluorination// Applied Radiation and Isotopes, 2002, V. 56, I. 3, p. 51 923.
50. Kitano H., Magata Y., Tanaka A., Mukai Т., Kuge Y., Nagatsu K., Konishi J., Saji H. Performance- assessment of 0−18 water purifier. Ann Nucl Med. 2001 V. 15(1), p. 75−8.
51. Reischl G., Kienzle G.J., Machulla H.J. Electrochemical radiofluorination. Part 2. Anodic monofluorination of substituted benzenes using 18 °F.fluoride// Applied Radiation and Isotopes, 2003, V. 58(6), p. 679−83.
52. Nickles R. J" Daube M. E. and Ruth T. J. An 1802 target for the production of1 о
53. F.F2//The International Journal of Applied Radiation and Isotopes, 1984, V. 35,1. 2, p. 117−122
54. Knust E. J. and Machulla H. -J. High yield production of 18 °F in a water target via16 3 18the 0(He, p) F reaction// The International Journal of Applied Radiation and Isotopes. 1983, V. 34,1. 12, p. 1627−1628
55. Zhang M.-R., Ogawa M., Furutsuka K., Yoshida Y. and Suzuki K. 18 18
56. F.Fluoromethyl triflate, a novel and reactive Fjfluoromethylating agent: Яpreparation and application to the on-column preparation of F. fluorocholine// Applied Radiation and Isotopes. 2002, V. 57,1. 3, p. 347−352
57. Oh S.-J., Choe Y.S., Chi D.Y., Kim S.E., Choi Y., Lee К., Ha H.-J. and Kim B.-T. Re-evaluation of 3-bromopropyl triflate as the percursor in the preparation of 3f Q
58. F.fluoropropyl bromide// Applied Radiation and Isotopes. 1999, V. 51,1. 3, p. 293 297чл
59. Jacobson К.А., Furlano D.C. and Kirk K.L. A prosthetic group for the rapid introduction of fluorine into peptides and functionalized drugs//Journal of Fluorine Chemistry. 1988, V. 39,1. 3, p. 339−347
60. Guhlke S., Coenen H.H. and Stocklin G. Fluoroacylation agents based on small n.c.a. 18P. fluorocarboxylic acids//Applied Radiation and Isotopes. 1994, V. 45, I. 6, p. 715−727
61. Lemaire C, Guillaume M, Cantineau R and Christiaens L. No-carrier-added1.Яregioselective preparation of 6- F. fluoro-L-dopa// Journal of Nuclear Medicine. 1990, V. 31,1. 7, p. 1247−1251
62. Plenevaux A., Lemaire C., Palmer A.J., Damhaut P. and Comar D. Synthesis of non-activated 18F-fluorinated aromatic compounds through nucleophilic substitution and decarboxylation reactions// Applied Radiation and Isotopes. 1992, V. 43, p. 10 351 040
63. Adam M. J. and Jivan S. Synthesis and purification of L-6-I8 °F.fluorodopa// International Journal of Radiation Applications and Instrumentation. Part A- Applied Radiation and Isotopes. 1988, V. 39,1. 12, p. 1203−1206
64. Adam M. J., Ruth T. J., Jivan S. and Pate B. D. Fluorination of aromatic1 Яcompounds with F2 and acetyl hypofluorite: synthesis of F-aryl fluorides by cleavage of aryl-tin bonds 1.// Journal of Fluorine Chemistry. 1984, V. 25, I. 3, p. 329−337
65. Fiichtner F. and Steinbach J. Efficient synthesis of the I8F-labelled 3−0-methyl-6-18 °F.fluoro-L-DOPA//Applied Radiation and Isotopes. 2003, V. 58,1. 5, p. 575−578
66. Hess E" Sichler S., Kluge A. and Coenen H. H. Synthesis of 2-18 °F.fluoro-i-tyrosine via regiospecific fluoro-de-stannylation// Applied Radiation and Isotopes. 2002, V. 57,1. 2, p. 185−191
67. Bishop A., Satyamurthy N., Bida G. and Barrio J.R. Chemical reactivity of the ,8 °F electrophilic reagents from the I80(p, n) I8 °F gas target systems// Nuclear Medicine and Biology. 1996, V. 23,1. 5, p. 559−565
68. Vlasov V.M.- Fluoride ion as a nucleophile and a leaving group in aromatic nucleophilic substitution reactions// Journal of Fluorine Chemistry. 1993, V. 61, p. 193−216.
69. Murray C.B., Sandford G. and Korn S.R. Ionic liquids as media for nucleophilic fluorination// Journal of Fluorine Chemistry, 2003, V. 123,1. 1, p. 81−84
70. Kim D.W., Choe Y.S. and Chi D.Y. A new nucleophilic fluorine-18 labeling method for aliphatic mesylates: reaction in ionic liquids shows tolerance for water// Nuclear Medicine and Biology. 2003, V. 30,1. 4, p. 345−350
71. Kim H.W., Jeong J.M., Lee Y.-S., Chi D.Y., Chung K.-H., Lee D.S., Chung J.-K. and Lee M.C. Rapid synthesis of 18 °F.FDG without an evaporation step using an ionic liquid// Applied Radiation and Isotopes. 2004, V. 61,1. 6, p. 1241−1246q9
72. Островский В А, Межфазный катализ органических реакций// СОЖ- 2000- V 6, № 11, стр 30−34пл
73. Hamacher К., Coenen Н. Н-, and Stocklin G. Efficient stereospecific synthesis of no-carrier-added- 2-18 °F.-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution// J. Nucl. Med. 1986, V. 27, p. 235−238.
74. Lemaire C. et al. No-carrier-added regioselective preparation of 6-i"F.fluoro-L-DOPA// J. Nucl. Med. 1990, V. 31, p. 1247−51.
75. Moerlein S. et al. Elimination of contaminant Kryptofix 2.2.2 in the routine production of 2-i8 °F.fluoro-2-deoxy-D-glucose// Int. J. Rad. Appl. Instrum. [A] 1989, V. 40(9), p. 741−3.
76. Katsifis A., Hamacher K., Schnitter J. and Stocklin G. Optimization studies concerning the direct nucleophilic fluorination of butyrophenone neuroleptics// Applied Radiation and Isotopes. 1993, V. 44,1. 7, p. 1015−1020
77. Mazza S.M. Stereospecific, semi-automated, N.C.A. syntheses of cis-41H •
78. F.fluoro-L-proline and trans-4−18F]fluoro-L-proline// Journal of Labelled Compounds and Radiopharmaceuticals. 2000- V. 43,1. 10, p. 1047−10 581. QO
79. Pascali G., Kiesewetter D.O., Salvadori P.A., Eckelman W.C. Use of 1,8-bis-(dimethyIamino)-naphthalene/H18 °F complex as new radiofluorinating agent// Journal of Labelled Compounds and Radiopharmaceuticals. 2004, V. 47,1. 6, p. 373−383
80. Белецкая И.П. «Ароматическое нуклеофильное замещение»// Соросовский Образовательный Журнал, том 7, N11, 2001, стр. 39−45
81. Miller J. Aromatic Nucleophilic Substitution//N.Y.: Elsevier, 1968.1 fi}
82. Власов B.M. Нуклеофильное замещение нитрогруппы, фтора и хлора в ароматических соединениях// Успехи химии, 2003, Том 72, N 8, стр. 764−786.
83. Марч Дж. Органическая химия//МИР, 1987, ТЗ, стр. 15−16
84. Rose-Munch F., Rose Е., Arenetricarbonylchromium Complexes: ipso, cine, tele Nucleophilic Aromatic Substitutions Chemlnform// 2004, V. 35,1. 27
85. Baldoli C., Buttero P.D. and Maiorana S. Aromatic nucleophilic substitution on halogenoarene tricarbonyl chromium complexes: synthesis of Cr (CO)3 complexed aniline derivatives//Tetrahedron Letters. 1992, V. 33,1. 28, p. 4049−4052
86. Rengan R., Chakraborty P.K., Kilbourn M.R. Can we predict reactivity for1 Яaromatic nucleophilic substitution with F. fluoride ion// J Label Compd Radiopharm. 1993, V. 33, p. 563−572-
87. Ding Y.S., Shiue C.Y., Fowler J.S., Wolf A.P., Plenevaux A.- No-carrier-added (NCA) aryl18 °F.fluorides via the nucleophilic aromatic substitution of electron-rich aromatic ring//Journal of Fluorine Chemistry, 1990, V. 48, p. 189−205.
88. Karramkam M., Hinnen F., Vaufrey F. and Dolle F. 2-, 3- and 41. Q
89. FJFluoropyridine by no-carrieradded nucleophilic aromatic substitution with KI8 °F.F-K222 a comparative study// J Label Compd Radiopharm. 2003, V. 46, p. 979−992-
90. Dolci L., Dolle F., Jubeau S., Vaufrey P., Crouzel C. 2−18F.fluoropyridines by1Яno-carrier-added nucleophilic aromatic substitution with F. FK-K222 a comparative study// J Label Compd Radiopharm. 1999, V. 42, p. 975−985-
91. Lasne M.-C., Perrio C., Rouden J., Barre L., Roeda D., Dolle F. and Crouzel C. Chemistry of B±Emitting Compounds Based on Fluorine-18, dans Topics in Current
92. Chemistry// V. 222, Krause W. Ed., Springer-Verlag Berlin Heidelberg 2002, p. 201 258.
93. Attma M., Cacace F., Wolf A.P. Labeled aryl fluorides from the nucleophilic displacement of activated nitro groups by 18F-FV/ J Label Compd Radiopharm. 1983, V. 20, p. 501−514
94. Zijlstra S., Gunawan J., Burchert W. Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET// Applied Radiation and Isotopes. 2003, V.58, p. 201−207
95. Ermert J., Носке С., Ludwig Т., Gail R., Coenen H.H. Comparison of pathways to the versatile synthon of no-carrier-added l-bromo-4-18 °F.fluorobenzene// Journal of Labelled Compounds and Radiopharmaceuticals. 2004, V. 47,1. 7, p. 429−441
96. Wust F.R., Kniess T. Synthesis of 4-18 °F.fluoroiodobenzene and its application in sonogashira cross-coupling reactions// J Label Compd Radiopharm. 2003, V. 46, p. 699−713.
97. Knochel A, Zwernemann O. J. Development of a No-carrier-added Method for 18F-Labelling of Aromatic Compounds by Fluorodediazonation// Label Compd Radiopharm. 1996- V. 38, p. 325−336.
98. Kilbourn R.M., Subramanian R. Synthesis of fluorine-18 labeled 1,1-difluoro-2,2-dichloroethyl aryl eathers by i8F-for-19 °F exchange// Journal of Labelled Compounds and Radiopharmaceuticals. 1990, V 25, p. 1355−13 611
99. Ndiokwere Ch. L. Fluorine labelling of ortho-fluorohippuric acid by isotope exchange reaction//. Journal of Labelled Compounds and Radiopharmaceuticals. V 14,1. 5, p. 705−712
100. Tewson TJ. Synthesis fluorine-18 lomefloxacin, a fluorinated quinoline antibiotic//J Lab Cmpds Radiopharm. 1993, V. 32, p. 145−146
101. Tewson TJ, Yang D, Wong G, Macy D, DeJesus OJ, Nickles RJ, Perlman SB, Taylor M, Frank P. The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies// Nuclear Medicine and Biology, 1996, V. 23, p. 767−772
102. Babich J.W., Rubin R.H., Graham W.A., Wilkinson R.A., Vincent J. and1. б
103. Fischman A.J. F-labeling and biodistnbution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219)// Nuclear Medicine and Biology. 1996, V. 23,1. 8, p. 995−998
104. Ermert J., Hamacher К., Coenen H.H. N.C.A. 18F-labelled norephedrine derivatives via a-aminopropiophenones// Journal of Labelled Compounds and Radiopharmaceuticals. 2000, V. 43, I. 14, p. 1345−1363
105. Cacace F., Speranza M., Wolf A.P. Fowler J.S. Labeling of fluorinated aromatics by isotopic exchange with 1SF. fluoride// Journal of Labelled Compounds and Radiopharmaceuticals. 1981, V. 18, I. 124, p. 1721−1 730 129
106. Сергеев ПВ, Шимановский НЛ- Рецепторы физиологически активных веществ//М. Медицина, 198 717П
107. Halldin С, Gulyas В, Langer О, Farde L- Brain radioligands -State of the art and newtrends//JNucl Med. 2001, V. 45, p. 139−152
108. Slifstein M. and Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers// Nuclear Medicine and Biology- 2001, V.28,1.5, p. 595−608 179 •
109. Gunn R.N., Gunn S.R., and Cunningham V.J. Positron Emission Tomography Compartmental Models. 2001// Journal of Cerebral Blood Flow and Metabolism. V. 21, p. 635−652
110. Millet P., Graf C., Buck A., Walder B. and Ibanez V. Evaluation of the Reference Tissue Models for PET and SPECT Benzodiazepine Binding Parameters// Neurolmage- 2002, V. 17,1. 2, p. 928−942
111. Wang Q., Han Y. and Xue H. Ligands of the GABAA Receptor Benzodiazepine Binding Site// CNS Drug Reviews. 1999, V. 5, N. 2, p. 125.144I
112. Hunkeler W. Benzodiazepines, the story of the antagonist Flumazenil and the partial agonist Bratazenil//Chimia. 1993, V. 47, p. 141−147
113. Maziere M., Prenant C., Sastre J. et al. Compt. Rend. Acad. Sci. Serie III, sciences de la vie. 1983. V. 296. p. 871−876.
114. Delforge J., Spelle L., Bendriem В., Samson Y., Syrota A. Parametric images of benzodiazepine receptor concentration using a partial-saturation injection// J Cereb Blood Flow Metab. 1997, V. 17(3), p. 343−55.
115. Millet P., Ibanez V., Delforge J., Pappata S., Guimon J. Wavelet Analysis of Dynamic PET Data: Application to the Parametric Imaging of Benzodiazepine Receptor Concentration// Neurolmage. 2000, V. 11,1. 5, p. 458−472
116. Blankenberg F.G., Strauss H. W. Nuclear Medicine Applications in Molecular Imaging. 2002// journal of magnetic resonance imaging, V. 16, p. 352−361
117. Bremner J.D., Horti A., Staib L.H., Zea-Ponce Y., Soufer R., Charney D.S., Baldwin R. Kinetic modeling of benzodiazepine receptor binding with PET and high specific activity nC. Iomazenil in healthy human subjects// Synapse. 2000, V. 35, I. 1, p. 68−77
118. Kieffer D., Cleynhens В., Verbeke K., Vanbilloen H., de Groot Т., Terwinghe C., Verbruggen A. and Bormans G. Synthesis, radio-LC-MS analysis and biological evaluation of 99mTc-techmazenil// J Label Compd Radiopharm. 2004, V. 47, p. 199 208.
119. Moerlein SM, Perlmutter JS.// J. Nucl. Med. 1990. V.31, p 902.
120. Moerlein SM, Perlmutter JS. Binding of 5-(2V-F-18.fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography// Eur. J. Pharmacol. 1992, V. 218, 109−115.
121. Yoon Y.H., Jeong J.M., Kim W.H., Hong S.H., Lee Y, Kil H.S., Lee M.C. Novel one-pot one-step synthesis of 2'-18 °F.fluoroflumazenil (FFMZ) for benzodiazepine receptor imaging// Nuclear Medicine and Biology. 2003, V. 30,1. 5, p. 521−527
122. Windhorst A.D., Klok R.K., Koolen G.L. Labelling of 18 °F.flumazenil via instant fluorination? A new nucleophilic fluorination methodI I Journal of Labelled Compounds and Radiopharmaceuticals. 2001. V. 44. S. 1. (abstract), p. 930 932.
123. Variation explained. STATISTICA 6, HELP
124. Титце JI. Ф., Айхер Т. Препаративная органическая химия//Мир, 1999 стр. 112
125. Hall Н, Farde L, Sedvall G. Human dopamine receptor subtypes in vitro binding analysis using зИ-SCH 23 390 and 3H-raclopride//J Neural Transm 1988, V. 73, p. 7−21.
126. Persson A, d’Argy R, Gillberg PG, Halldin G, Litton J-E, Swahn C-G, et-al. Autoradiography with saturation experiments of nC. Ro 15−1788 binding to human brain sections//J Neurosci Methods. 1991, V. 36, p. 53−61.
127. Karlsson P, Farde L, Halldin C, Swahn C-G, Sedvall G, Foged C, et al. PET examination of nC. NNC 687 and [nC]NNC 756 as new radioligands for the D,-dopamine receptor//Psychopharmacology. 1993, V. 113, p. 149- 156.
128. De Vries E.F.G. Vaalburg W. Labeling of cyclooxygenase-2 inhibitors DuP-697 and its desbromo derivative: the crucial role of the solvent// Journal of Labelled Compounds and Radiopharmaceuticals. 2001, V. 44, Suppl. 1, p. 933−935
129. Axelsson S. nC/14C and I8F/19 °F kinetic isotope effects// Comprehensive Summaries of Uppsala Dissertation from the Faculty of Science. 1989, ISBN 91−5 542 475−9, p. 381 *71
130. Cervera M., Marquet J. and Martin X. Charge control in the SNAr reaction. Meta substitution with respect to the activating nitro group in 3,4-dihalogenonitrobenzenes. //Tetrahedron, 1996, V. 52,1. 7, p. 2557−2564
131. Savic I., Svanborg E., Thorel J.O. Cortical benzodiazepine receptor changes are related to frequency of partial seizures. A PET study// Epelepsia, 1996, V. 37,1. 3, p. 236−244:
132. Windhorst A.D., Mooijer M.P.J., Klok R.P., Visser G.W.M., Herscheid J.D.M. Synthesis and purification of li (F.flumazenil and in vivocomparison with [nC]flumazenil in rats. 2003// Journal of Labelled Compounds and Radiopharmaceuticals., V. 46, p. 148.
133. Ryzhikov N., Seneca N., Krasikova R.N., Gomzina N.A., Shchukin E.,
134. Halldin C, Swahn C-G, Farde L. Radioligand disposition and metabolism — key information in early drug development. In: Comar D, editor. PET for Drug development and evaluation. San Diego (CA)7 Elsevier- 1995- p. 55−65.
135. Persson A, Pauli S, Swahn C-G, Halldin C, Sedval G. Cerebral uptake of nC-Ro 15−1788 and its acid metabolite uC-Ro 15−3890- PET study in healthy volunteers// Hum Psychoparmacol. 1989, V. 4, p. 215- 220.